(There will be no Canada market report on Monday, Jan. 3, due
to New Year's Day holiday)
By Amal S
Dec 31 (Reuters) - Canada's main stock index fell in thin
trading on Friday, but was on course to mark its best year since
2009 thanks to massive stimulus, COVID-19 vaccine rollouts and
hopes of global economic recovery.
At 9:40 a.m. ET (14:40 GMT), the Toronto Stock Exchange's
S&P/TSX composite index .GSPTSE was down 29.96 points, or
0.14%, at 21,264.68, with technology .SPTTTK stocks leading
losses.
The energy sector .SPTTEN climbed 0.2%, even though U.S.
crude CLc1 prices were down 0.9% a barrel, while Brent crude
LCOc1 lost 0.8%. O/R
The financials sector .SPTTFS slipped 0.2%, while the
industrials sector .GSPTTIN fell 0.3%.
Limiting losses were healthcare stocks .GSPTTHC that
gained 0.4%, helped by pot shares Tilray Inc TLRY.TO , Canopy
Growth Corp WEED.TO , Aurora Cannabis Inc ACB.TO rising
nearly 2% each.
The materials sector .GSPTTMT , which includes precious and
base metals miners and fertilizer companies, added 0.1% as gold
futures GCc1 rose 0.7% to $1,825.6 an ounce. GOL/
The benchmark equity index has gained 22% so far this year,
with energy stocks surging the most as oil prices rebounded from
the pandemic-induced slump on reopening economies.
Healthcare stocks were the weakest as they have lost nearly
22% in 2021 due to tax-loss selling, mostly toward the end of
the year.
"Generally speaking, 2021 has been a choppy year for
markets. Sector action was very mixed, particularly through the
middle part of the year which saw a series of rolling takedowns
and rebounds," said Colin Cieszynski, chief market strategist at
SIA Wealth Management.
HIGHLIGHTS
The TSX posted one new 52-week highs and no new lows.
Across all Canadian issues, there were 10 new 52-week highs
and two new lows, with a total volume of 13.94 million shares.
(Reporting by Amal S in Bengaluru; Editing by Ramakrishnan M.)
((Amal.S@thomsonreuters.com; within U.S. +1 646 223 8780;
outside U.S. +91 80 6749 3677;))